Maria Grazia Bernengo, Pietro Quaglino, Alessandra Comessatti, Michela Ortoncelli, Mauro Novelli, Francesco Lisa, Maria Teresa Fierro. Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. haematol [Internet]. 2007Jun.1 [cited 2024Nov.23];92(6):784-9. Available from: https://haematologica.org/article/view/4472